DC

David Chaplin

OX Oxigene: 13 patents #1 of 35Top 3%
BU Baylor University: 11 patents #7 of 141Top 5%
Overall (All Time): #252,963 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11419934 Use of VDAS to enhance immunomodulating therapies against tumors Kimberly Perkins 2022-08-23
9873668 Compositions and methods for inhibition of cathepsins Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick 2018-01-23
9458103 Compositions and methods for inhibition of cathepsins Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick 2016-10-04
RE45907 Functionalized stilbene derivatives as improved vascular targeting agents Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen 2016-03-01
RE45720 Functionalized stilbene derivatives as improved vascular targeting agents Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen 2015-10-06
9040500 Method for treating hematopoietic neoplasms Bronwyn G. Siim 2015-05-26
8877967 Compositions and methods for inhibition of cathepsins Kishore Kumar Gaddale Devanna, Erica Parker, Kevin G. Pinney, Jiangli Song, Mary Lynn Trawick 2014-11-04
8198302 Compositions and methods with enhanced therapeutic activity Klaus Edvardsen, Kevin G. Pinney, Joseph Prezioso, Mark Wood 2012-06-12
7456214 Chromene-containing compounds with anti-tubulin and vascular targeting activity Kevin G. Pinney, Phyllis Arthasary, Anupama Shirali, Klaus Edvardsen 2008-11-25
7384925 Functionalized stilbene derivatives as improved vascular targeting agents Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen 2008-06-10
7358236 Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents Scott Young 2008-04-15
7091240 Tubulin binding ligands and corresponding prodrug constructs Kevin G. Pinney, Vani P. Mocharla, Zhi Chen, Charles Garner, Mallinath Hadimani +5 more 2006-08-15
7001926 Tubulin binding agents and corresponding prodrug constructs Kevin G. Pinney, Vani P. Mocharla, Zhi Chen, Mallinath Hadimani, Jimmy Kessler +4 more 2006-02-21
6919324 Functionalized stilbene derivatives as improved vascular targeting agents Charles Garner, Robert R. Kane, Kevin G. Pinney, Joseph Prezioso, Klaus Edvardsen 2005-07-19
6713517 Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use Ronald W. Pero, Anders Olsson, Tomas Ekberg, Alan Schwartz 2004-03-30
6028111 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents Ronald W. Pero 2000-02-22
5026694 Platinum complexes with one radiosensitizing ligand Kirsten A. Skov, Nicholas Farrell 1991-06-25
4921963 Platinum complexes with one radiosensitizing ligand Kirsten A. Skov, Nicholas Farrell 1990-05-01